High-dose vitamin C: A promising anti-tumor agent, insight from mechanisms, clinical research, and challenges
March 2026
Vitamin C, also known as ascorbic acid, has sparked controversy since it first emerged as a potential anti-cancer agent. However, an increasing number of preclinical studies have demonstrated that high-dose...
Cancer chemotherapy and beyond: Current status, drug candidates, associated risks and progress in targeted therapeutics
July 2023
Cancer is an abnormal state of cells where they undergo uncontrolled proliferation and produce aggressive malignancies that causes millions of deaths every year. With the new understanding of the molecular...
Breast cancer development and progression: Risk factors, cancer stem cells, signaling pathways, genomics, and molecular pathogenesis
June 2018
As the most commonly occurring cancer in women worldwide, breast cancer poses a formidable public health challenge on a global scale. Breast cancer consists of a group of biologically and molecularly...
Platinum-resistant ovarian cancer: From mechanisms to treatment strategies
March 2026
Over the last few decades, platinum-based chemotherapy has served as the standard chemotherapy in treating ovarian cancer (OC). While most patients initially respond well to platinum-based chemotherapy,...
Optimized Yamanaka factors combined with TERT gene therapy for enhanced anti-aging effects
March 2026
Genetics, epidemiology and management of clubfoot and related disorders
November 2025
Clubfoot, medically termed congenital talipes equinovarus (CTEV), is a prevalent musculoskeletal birth defect, affecting approximately 0.3% of all live births. This serious congenital anomaly results...
Age-related macular degeneration: Epidemiology, genetics, pathophysiology, diagnosis, and targeted therapy
January 2022
Age-related macular degeneration (AMD) is a complex eye disorder and is the leading cause of incurable blindness worldwide in the elderly. Clinically, AMD initially affects the central area of retina...
Recent advances in human papillomavirus vaccines and therapeutic strategies: Combating cervical and non-cervical cancers
May 2026
Human papillomaviruses (HPV) are a major cause of several cancers, particularly cervical cancer, and remain a serious public health challenge, particularly in low-resource countries. In addition to...
Pretreating and normalizing metabolomics data for statistical analysis
May 2024
Metabolomics as a research field and a set of techniques is to study the entire small molecules in biological samples. Metabolomics is emerging as a powerful tool generally for precision medicine. Particularly,...
Canonical and noncanonical Wnt signaling: Multilayered mediators, signaling mechanisms and major signaling crosstalk
January 2024
Wnt signaling plays a major role in regulating cell proliferation and differentiation. The Wnt ligands are a family of 19 secreted glycoproteins that mediate their signaling effects via binding to Frizzled...
Genetics of severe combined immunodeficiency
March 2020
Severe Combined Immunodeficiency (SCID) is an inherited group of rare, life-threatening disorders due to the defect in T cell development and function. Clinical manifestations are characterised by recurrent...
Depletion of Kif13b promotes neuroinflammatory attack against myelin in an experimental autoimmune encephalomyelitis mouse model
September 2026
Melanoma: Molecular genetics, metastasis, targeted therapies, immunotherapies, and therapeutic resistance
November 2022
Cutaneous melanoma is a common cancer and cases have steadily increased since the mid 70s. For some patients, early diagnosis and surgical removal of melanomas is lifesaving, while other patients typically...
The hidden Markov model and its applications in bioinformatics analysis
January 2026
Big biological data contains a large amount of life science information, yet extracting meaningful insights from this data remains a complex challenge. The hidden Markov model (HMM), a statistical model...
In vivo CAR-T for the treatment of autoimmune diseases: Current progress and future directions
Available online 19 May 2026
Autoimmune diseases are a clinical challenge because current immunosuppressive therapies fail to eliminate pathogenic immunocytes, such as autoreactive B cells, plasma cells, and antigen-presenting...
Dendritic cell vaccines: Current research progress, challenges, and opportunities
July 2026
This review examines the advancements in cancer immunotherapies, particularly focusing on dendritic cell (DC)-based vaccines developed through in vitro methods. DCs are essential for connecting innate...
DNA-based vaccines: Advances, applications, and future prospects
November 2026
DNA-based vaccines represent a promising advancement in immunization strategies, offering a novel approach for preventing infectious diseases and treating various conditions, including cancers and autoimmune...
Advances in the mechanism and therapies of achondroplasia
July 2025
Achondroplasia (ACH), is the prevailing type of genetic dwarfism in humans, caused by mutations in fibroblast growth factor receptor 3 (FGFR3) that are inherited in an autosomal dominant manner. FGFR3...
Oncogenic activation of PIK3CA in cancers: Emerging targeted therapies in precision oncology
March 2025
Phosphoinositide 3-kinases (PI3Ks) are heterodimers consisting of a p110 catalytic subunit and a p85 regulatory subunit. The PIK3CA gene, which encodes the p110α, is the most frequently mutated oncogene...
In vivo production of CAR T cell: Opportunities and challenges
November 2025
Chimeric antigen receptor T (CAR T) cell therapy has achieved remarkable efficacy for patients with hematological malignancies. However, in vitro viral vector-mediated production of CAR T cells is time-consuming...
Anaplastic thyroid cancer: Genetic roles, targeted therapy, and immunotherapy
July 2025
Anaplastic thyroid cancer (ATC) stands as the most formidable form of thyroid malignancy, presenting a persistent challenge in clinical management. Recent years have witnessed a gradual unveiling of...
The oncogenic role of CCDC178 in intrahepatic cholangiocarcinoma through LGR4-dependent signaling and immune modulation
September 2026
Mechanism of PARP inhibitor resistance and potential overcoming strategies
January 2024
PARP inhibitors (PARPi) are a kind of cancer therapy that targets poly (ADP-ribose) polymerase. PARPi is the first clinically approved drug to exert synthetic lethality by obstructing the DNA single-strand...
Differences between lung adenocarcinoma and lung squamous cell carcinoma: Driver genes, therapeutic targets, and clinical efficacy
May 2025
With the rapid advancements in second-generation gene sequencing technologies, a growing number of driver genes and associated therapeutic targets have been unveiled for lung adenocarcinoma (LUAD) and...
Clinical applications of the CRISPR/Cas9 genome-editing system: Delivery options and challenges in precision medicine
January 2024
CRISPR/Cas9 is an effective gene editing tool with broad applications for the prevention or treatment of numerous diseases. It depends on CRISPR (clustered regularly interspaced short palindromic repeats)...